Precision BioSciences Inc. (DTIL)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
| |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
8 |
$128,390 |
Sells |
8 |
$301,009 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
28 Mar 2025 |
BUEHLER KEVIN |
Director |
26 Mar 2025 |
4,523 |
4.67 |
21,122 |
28 Mar 2025 |
BROWN MELINDA |
Director |
26 Mar 2025 |
1,839 |
4.75 |
8,735 |
27 Mar 2025 |
GERMANO GENO J |
Director |
25 Mar 2025 |
3,250 |
5.30 |
17,225 |
02 Jan 2025 |
GERMANO GENO J |
Director |
30 Dec 2024 |
3,605 |
4.49 |
16,186 |
31 Dec 2024 |
BUEHLER KEVIN |
Director |
27 Dec 2024 |
4,320 |
4.88 |
21,082 |
31 Dec 2024 |
KELLY JOHN ALEXANDER |
Chief Financial Officer |
27 Dec 2024 |
2,113 |
4.75 |
10,037 |
30 Dec 2024 |
BROWN MELINDA |
Director |
26 Dec 2024 |
3,016 |
4.55 |
13,723 |
21 Nov 2024 |
KELLY JOHN ALEXANDER |
Chief Financial Officer |
21 Nov 2024 |
3,000 |
6.76 |
20,280 |
21 Mar 2023 |
KELLY JOHN ALEXANDER |
Chief Financial Officer |
17 Mar 2023 |
20,000 |
0.86 |
17,200 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock